Delving into the Latest Updates on Haining Lvsheng Medical Technology Co., Ltd. with Synapse

Overview

Tags

Respiratory Diseases

Neoplasms

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	1

主要目的：评价注射用LS-HB在晚期恶性肿瘤受试者中的安全性及耐受性，并确定注射用LS-HB的II期推荐给药剂量（RP2D）和光动力治疗（PDT）参数。次要目的：评价注射用LS-HB在晚期恶性肿瘤受试者中的药代动力学（PK）特征和初步有效性。

[Translation]

Primary objective: To evaluate the safety and tolerability of LS-HB for injection in subjects with advanced malignant tumors, and to determine the Phase II recommended dose (RP2D) and photodynamic therapy (PDT) parameters of LS-HB for injection. Secondary objective: To evaluate the pharmacokinetic (PK) characteristics and preliminary efficacy of LS-HB for injection in subjects with advanced malignant tumors.

Start Date04 Dec 2023

Sponsor / Collaborator

Haining Lvsheng Medical Technology Co., Ltd.

100 Clinical Results associated with Haining Lvsheng Medical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Haining Lvsheng Medical Technology Co., Ltd.

Login to view more data

100 Deals associated with Haining Lvsheng Medical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Haining Lvsheng Medical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Jul 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Login to view more data